ARGAN INC·4

Jun 17, 4:30 PM ET

Getsinger Peter W 4

4 · ARGAN INC · Filed Jun 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Argan (AGX) Director Peter Getsinger Exercises Options, Sells Shares

What Happened
Peter W. Getsinger, a director of Argan, Inc. (AGX), exercised stock options and promptly sold shares. On June 15, 2026 he exercised an option awarded Dec 16, 2022 to purchase 5,000 shares at $35.72 each (net-settle). As reported, 4,728 shares were acquired at $35.72 (cost ~$168,884) and then 4,728 shares were sold on June 16, 2026 for an average of $708.65 ($3,350,497). He also sold 2,000 additional shares on June 17, 2026 at an average of $699.00 ($1,398,000). Total open-market proceeds reported: ~$4.75 million.

Key Details

  • Transaction dates and prices:
    • 2026-06-15: Exercised option to purchase 5,000 shares at $35.72 (net-settle) — exercise cost ~$178,600 (footnote F1).
    • 2026-06-15: 4,728 shares reported acquired at $35.72 — $168,884 (transaction code M, footnote F1).
    • 2026-06-16: Sold 4,728 shares at an average $708.65 — proceeds ~$3,350,497 (footnote F2).
    • 2026-06-17: Sold 2,000 shares at an average $699.00 — proceeds $1,398,000 (footnote F3).
  • Shares owned after the transactions: not specified in the provided filing.
  • Notable footnotes: F1 confirms the June 15 exercise used the net-settle method (common for covering exercise cost/withholding). F2 and F3 describe the open-market sales on June 16–17.
  • Filing timeliness: Report filed June 17, 2026 for a 6/15/2026 transaction — appears to have been filed within the typical 2-business-day Form 4 window.

Context

  • This was an option exercise followed by immediate open-market sales (a common cashless/near-cashless pattern): options were exercised and shares were sold soon after. Such sales often reflect option liquidity or tax/exercise-related actions rather than a definitive view on the company’s outlook.
  • The largest items here are sales (total proceeds ~ $4.75M); purchases consist of the option exercise at a low strike ($35.72) relative to the sale prices (~$699–708), producing substantial realized gain on the exercised shares.

Insider Transaction Report

Form 4
Period: 2026-06-15
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-06-15$35.72/sh+4,728$168,88411,608 total
  • Sale

    Common Stock

    [F2]
    2026-06-16$708.65/sh4,728$3,350,4976,880 total
  • Sale

    Common Stock

    [F3]
    2026-06-17$699.00/sh2,000$1,398,0004,880 total
  • Exercise/Conversion

    Option to Purchase Common Stock

    [F1]
    2026-06-15$35.72/sh5,000$178,6003,000 total
    Exercise: $35.72From: 2023-12-16Exp: 2033-12-16Common Stock (5,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    267
  • Common Stock

    (indirect: By Children)
    133
Footnotes (3)
  • [F1]On June 15, 2026, the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share using the net settle method.
  • [F2]On June 16, 2026, the Reporting Person sold 4,728 shares of the Issuer's common stock on the open market at an average price of $708.65 per share.
  • [F3]On June 17, 2026, the Reporting Person sold 2,000 shares of the Issuer's common stock on the open market at an average price of $699.00 per share.
Signature
/s/ Peter W. Getsinger|2026-06-17

Documents

1 file
  • 4
    form4-06172026_040601.xmlPrimary